Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s402362 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Fahad S Alshehri. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia. Hauptthemen laut MEDLINE: Tramadol, Neuralgia, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
ORCID-Profile: Fahad S Alshehri
Zitieren
APA
Alshehri, F. S. (2023). Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s402362
Vancouver
Alshehri FS. Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s402362
BibTeX
@article{Alshehri2023,
author = {Alshehri, Fahad S},
title = {Tapentadol: A Review of Experimental Pharmacology Studies, Clinical Trials, and Recent Findings},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s402362}
}
EUVIMED